
Amlocard Plus5 mg+25 mg
Drug International Ltd.
Amlodipine + Atenolol is a fixed-dose combination antihypertensive indicated for the treatment of hypertension in patients who require combination therapy for adequate blood pressure control and more.
Amlodipine + Atenolol is a fixed-dose combination antihypertensive indicated for the treatment of hypertension in patients who require combination therapy for adequate blood pressure control, typically when blood pressure is not adequately controlled on either component alone.
Amlodipine + Atenolol is not intended as initial single-agent therapy for patients who have not first been tried on, or found intolerant to, monotherapy, unless the treating physician determines combination therapy is appropriate from the outset based on the degree of blood pressure elevation.
| Indication | Typical Dose |
|---|---|
| Hypertension requiring combination therapy | One tablet (commonly amlodipine 5 mg + atenolol 25 mg, or amlodipine 5 mg + atenolol 50 mg) once daily, taken at approximately the same time each day. |
| Dose titration | The dose may be increased, or the strength adjusted, by the treating physician based on individual blood pressure response, typically not exceeding a maximum equivalent to amlodipine 10 mg + atenolol 100 mg daily. |
Amlodipine + Atenolol is not recommended for use in children; safety and efficacy of this fixed-dose combination in pediatric patients have not been established (see Use in Special Populations).
Because atenolol is predominantly renally excreted, dose reduction and/or extended dosing intervals of Amlodipine + Atenolol are required in patients with reduced renal function; a lower starting dose and close monitoring are advised, and use in severe renal impairment should be under specialist guidance.
Amlodipine is extensively metabolized by the liver; patients with hepatic impairment may need a lower starting dose of Amlodipine + Atenolol and slower titration, with close monitoring for hypotension and other adverse effects.
Amlodipine + Atenolol should be taken orally, once daily, with or without food, swallowed whole with water. Do not stop taking Amlodipine + Atenolol abruptly (see Precautions and Warnings).
Most patients tolerate Amlodipine + Atenolol well. Reported adverse effects reflect both components:
Patients should seek prompt medical advice for severe dizziness, fainting, very slow heart rate, marked swelling, or breathing difficulty while taking Amlodipine + Atenolol.
Amlodipine + Atenolol is contraindicated in patients with:
Severe bronchospastic disease (e.g., severe asthma) is generally considered a contraindication to beta-blocker-containing products such as Amlodipine + Atenolol, even though atenolol's beta-1 selectivity reduces (but does not eliminate) the risk of bronchospasm; use in such patients should be avoided.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.